Meet
Elizabeth Crevier

Associate Principal

Elizabeth Crevier supports clients in conducting research and evaluating evidence on patient-centric care value and disease burden, often leveraging real-world data.

Before joining Avalere, Elizabeth conducted clinical research on type 1 diabetes at the Naomi Berrie Diabetes Center at New York Presbyterian Hospital. Previously, she served as associate director of a nonprofit providing low-income patients access to breast cancer care in New York City. She worked in translational research focused on autism spectrum disorder and chronic fatigue syndrome at the Center for Infection and Immunity, in market research focused on qualitative and mixed methods research, and in patient advocacy consulting as a scientific director.​

Elizabeth holds a bachelor’s degree in biology and neuroscience from Trinity College, and a Master of Public Health with a focus on epidemiology from Columbia University's Mailman School of Public Health.

Authored Content


The USPSTF develops independent, evidence-based preventive recommendations through an evidence-based review process. Avalere Health helps organizations successfully navigate, engage, and influence these processes.

A retrospective FFS claims analysis of adults with β-thalassemia found limited differences in most related healthcare resource utilization or cost categories before and after luspatercept use among those with transfusion-dependent β-thalassemia.

Avalere Health Advisory is accepting applications for its pro bono grant program, awarding donated or deeply discounted consulting services for projects dedicated to improving healthcare delivery, access, and outcomes.

Policymakers, professional societies, and advocates support the preservation of USPSTF’s evidence-based recommendations and independence amid reported plans for a sweeping overhaul.

Reported plans to reshape the USPSTF align with recent changes to ACIP and may shape the future of preventive care recommendations and access.

Avalere Health helps innovators shape USPSTF recommendations, driving preventive care access, payer coverage, and clinical adoption.

In Kennedy v. Braidwood, the Supreme Court affirmed HHS’s USPSTF appointment power, keeping the ACA’s no-cost preventive-service mandate fully in force.

If finalized, the President’s FY 2026 proposed budget cuts and restructuring of AHRQ is anticipated to impede key USPSTF activities.

Avalere Health launches a new pro bono initiative, offering free Advisory services to non-profit organizations looking to reach EVERY PATIENT POSSIBLE. The company is now accepting applications for Fall 2025.

The Supreme Court weighs a case that could reshape access to no-cost preventive services under the ACA and redefine USPSTF's legal authority

Life sciences companies, payers, and advocates can weigh in on patient-centered value assessments in a new public comment opportunity.

Continued emphasis on diabetes management technology and patient-centered care in updated clinical management standards highlight the importance of advancing quality measurement.

In this installment of our 2024 Trends Influencing Rare Disease series, Avalere experts dive into patient centricity trends in rare disease.

Innovative research methods can be used to measure the total burden of rare disease, including direct medical costs, indirect costs, and overall life impacts.

In the next installment of our 2023 Top Trends in HEOR series, Avalere experts dive into Trend #7: Value Assessment.

Avalere identified the top trends in HEOR. In this Insight, Avalere experts dive into Trend #7: Value Assessment, and explore important considerations for stakeholders in utilizing this vital tool.